drugset
Drugs / Meningococcal C-CRM Conjugate Vaccine
last change Aug 2017 re-read 3 minutes ago

Meningococcal C-CRM Conjugate Vaccine

also known as MenC-CRM

Vaccine

Developed for
meningococcal infection

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1 NCT02639351 Comparator Mar 2016 → Aug 2017 meningococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Meningococcal C-CRM Conjugate Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02639351 ↗
Known as MenC-CRM “Meningococcal C-CRM Conjugate Vaccine (MenC-CRM)” NCT02639351 ↗
Modality Vaccine “investigational Meningococcal C-CRM conjugate vaccine (MenC-CRM)” NCT02639351 ↗